Arcus, Inc.

YARDLEY, PA · Founded 2016 · CIK 0001798337 · Biotech · Public

Cancer therapeutics developed through collaborative scientific and clinical research

arcusbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$35K
1 Form D · Jan 2020
80 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$35,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2675Qu Biologics Inc.—$49K
2676Sequence46, LLC—$48K
2677Forkhead Biotherapeutics, Inc.——
2678Arcus, Inc.—$35K
2679Extended Longevity, Inc.—$10K
2680EIGER GROUP INTERNATIONAL, INC.——
2681MOLECULAR WORLD HEALTH, INC.—$5K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Gerard MurphyDirector · Executive Officer
  • Paul StringerDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.